Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Pharmacology & Therapeutics|June 6, 2009
Kappa-opioid ligands in the study and treatment of mood disordersWilliam A Carlezon, Cécile Béguin, Allison T Knoll, et al.Bioorganic & Medicinal Chemistry|May 15, 2004
N-Substituted amino acid N'-benzylamides: synthesis, anticonvulsant, and metabolic activitiesCécile Béguin, Arnaud LeTiran, James P Stables, et al.Journal of Medicinal Chemistry|April 16, 2004
Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compoundsMin Shen, Cécile Béguin, Alexander Golbraikh, et al.Brain Research|September 4, 2012
Effects of the anticonvulsant lacosamide compared to valproate and lamotrigine on cocaine-enhanced reward in ratsCécile Béguin, David N Potter, William A Carlezon, et al.Bioorganic & Medicinal Chemistry|September 3, 2003
Functionalized amido ketones: new anticonvulsant agentsCécile Béguin, Shridhar V Andurkar, Albert Y Jin, et al.Neuropharmacology|July 14, 2009
Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residenceJacob M Hooker, Thomas A Munro, Cécile Béguin, et al.Bioorganic & Medicinal Chemistry Letters|June 17, 2006
Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18)Cécile Béguin, Michele R Richards, Jian-Guo Li, et al.BMC Pharmacology|May 31, 2012
Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicityThomas A Munro, Loren M Berry, Ashlee Van't Veer, et al.Bioorganic & Medicinal Chemistry|November 6, 2007
Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethersThomas A Munro, Katharine K Duncan, Wei Xu, et al.Psychopharmacology|April 2, 2010
Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in ratsChristina L Nemeth, Tracie A Paine, Joseph E Rittiner, et al.Pageof 2